Literature DB >> 19804569

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction.

Ravindra Sarode1, Majed A Refaai, Karen Matevosyan, James D Burner, Scott Hampton, Cynthia Rutherford.   

Abstract

BACKGROUND: Plasma and platelets (PLTs) are often transfused to correct mild to moderately abnormal laboratory values. Our objective was to reduce unnecessary plasma and PLT transfusions to nonbleeding patients by prospective triage and education of end users in evidence-based hemostasis and transfusion medicine practices. STUDY DESIGN AND METHODS: Using the Parkland Memorial Hospital's transfusion service and admission database as the data source, this study comprises the comparison of transfusion data on plasma and PLT use between pre- (2000-2002) and posttriage (2003-2006) periods. Yearly transfusion and wastage data on red blood cells (RBCs), plasma, and PLTs and yearly hospital admissions, trauma visits, and surgical procedures were extracted retrospectively for the study.
RESULTS: The study revealed that implementation of triage resulted in a significant reduction of plasma (60%) and PLT (25%) transfusions, saving more than $3,000,000 over 4 years.
CONCLUSIONS: Prospective triage and evidence-based transfusion practice education reduced unnecessary plasma and PLT transfusions and health care costs.

Entities:  

Mesh:

Year:  2009        PMID: 19804569     DOI: 10.1111/j.1537-2995.2009.02413.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Kwan Mi Pack; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

2.  Evaluation of RBC Transfusion Practice in Adult ICUs and the Effect of Restrictive Transfusion Protocols on Routine Care.

Authors:  Kevin P Seitz; Jonathan E Sevransky; Greg S Martin; John D Roback; David J Murphy
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

3.  Antimicrobial blue light for decontamination of platelets during storage.

Authors:  Min Lu; TianHong Dai; SiSi Hu; Qi Zhang; Brijesh Bhayana; Li Wang; Mei X Wu
Journal:  J Biophotonics       Date:  2019-08-29       Impact factor: 3.207

Review 4.  Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.

Authors:  Allen W Bryan; Elizabeth M Staley; Timothy Kennell; Alexander Z Feldman; Lance A Williams; Huy P Pham
Journal:  Lab Med       Date:  2017-05-01

5.  Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function.

Authors:  José Paul Perales Villarroel; Ronald Figueredo; Yuxia Guan; Maurizio Tomaiuolo; Mehmet A Karamercan; John Welsh; Mary A Selak; Lance B Becker; Carrie Sims
Journal:  J Surg Res       Date:  2013-06-19       Impact factor: 2.192

6.  Blood conservation strategies at United States hospitals during the COVID-19 pandemic: Findings from a multi-institutional analysis - International Society of Blood Transfusion survey.

Authors:  Jeremy W Jacobs; Matthew S Karafin; Elizabeth S Allen; Elizabeth Abels; Yara A Park; Laura D Stephens; Dawn C Ward; Jennifer S Woo; Eric A Gehrie; Garrett S Booth; Brian D Adkins
Journal:  Transfusion       Date:  2022-09-12       Impact factor: 3.337

7.  Plasma Transfusion Practice in Adult Surgical Patients: Systematic Review of the Literature.

Authors:  Elisabeth Hannah Adam; Dania Fischer
Journal:  Transfus Med Hemother       Date:  2020-09-18       Impact factor: 3.747

8.  Portuguese Consensus and Recommendations for Acquired Coagulopathic Bleeding Management (CCBM).

Authors:  Manuela Gomes; Anabela Rodrigues; Alexandre Carrilho; José Aguiar; Luciana Gonçalves; Fernando Fernandez-Llimos; Filipa Duarte-Ramos; Joana Rodrigues
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.